Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), released financial results for the third quarter ended September 30, 2022.

Q3 2022 Financial Highlights

Operational Highlights and Pipeline Update

Zygel in Fragile X Syndrome (FXS)

Zygel in 22q11.2 Deletion Syndrome (22q)

Full story available on Benzinga.com